WAM
COEPW

Wolverine Asset Management’s Coeptis Therapeutics Warrants COEPW Stock Holding History

Wolverine Asset Management’s Portfolio COEPW Stock Details COEPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-27,888
Closed -$418 – 1648
2024
Q3 		$418 Hold
27,888
– – ﹤0.01% 1567
2024
Q2 		$836 Sell
27,888
-5,618
-17% -$141 ﹤0.01% 1553
2024
Q1 		$854 Hold
33,506
– – ﹤0.01% 1528
2023
Q4 		$1.04K Buy
33,506
+1,017
+3% +$40 ﹤0.01% 1606
2023
Q3 		$734 Buy
32,489
+9,555
+42% +$391 ﹤0.01% 1724
2023
Q2 		$1.64K Buy
22,934
+6,569
+40% +$783 ﹤0.01% 1595
2023
Q1 		$2.41K Sell
16,365
-17,282
-51% -$2.23K ﹤0.01% 1625
2022
Q4 		$3.36K Buy
+33,647
New +$2.25K ﹤0.01% 1796
2021
Q1 		– Sell
-6,321
Closed -$8K – 2056
2020
Q4 		$8K Buy
+6,321
New +$5.83K ﹤0.01% 1511

Other funds holding COEPW

MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
SIA
SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
HHGC
Hunting Hill Global Capital New York $129M AUM 17.34% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Wolverine Asset Management's COEPW Position: Q4 2024 in Review

Wolverine Asset Management sold out of Coeptis Therapeutics Warrants (COEPW) in Q4 2024, closing a stake of 27,888 shares — an estimated $418 sold.

Wolverine Asset Management first reported a position in COEPW in Q4 2020 and held it in 9 quarters. The position peaked at $8K in Q4 2020. 13 funds tracked by Wall St. Rank hold COEPW as of Q4 2024.

  • Wolverine Asset Management reported no remaining Coeptis Therapeutics Warrants position as of Q4 2024 after selling out during the quarter.
  • Wolverine Asset Management sold 27,888 Coeptis Therapeutics Warrants shares in Q4 2024, an estimated $418.
  • Wolverine Asset Management first reported a position in Coeptis Therapeutics Warrants in Q4 2020 and held it in 9 quarters.
  • Wolverine Asset Management's Coeptis Therapeutics Warrants position peaked at $8K in Q4 2020.
  • 13 funds tracked by Wall St. Rank held Coeptis Therapeutics Warrants as of Q4 2024.

Based on Wolverine Asset Management's 13F filing for Q4 2024, filed 3 Feb 2025.